Literature DB >> 21195080

Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques.

Viraj Kulkarni1, Rashmi Jalah, Brunda Ganneru, Cristina Bergamaschi, Candido Alicea, Agneta von Gegerfelt, Vainav Patel, Gen-Mu Zhang, Bhabadeb Chowdhury, Kate E Broderick, Niranjan Y Sardesai, Antonio Valentin, Margherita Rosati, Barbara K Felber, George N Pavlakis.   

Abstract

Optimized DNA vectors were constructed comprising the proteome of SIV including the structural, enzymatic, regulatory, and accessory proteins. In addition to native antigens as produced by the virus, fusion proteins and modified antigens with altered secretion, cellular localization and stability characteristics were generated. The DNA vectors were tested for expression upon transfection in human cells. In addition, the vectors were tested either alone or in combinations in mice and macaques, which provided an opportunity to compare immune responses in two animal models. DNA only immunization using intramuscular injection in the absence or presence of in vivo electroporation did not alter the phenotype of the induced T cell responses in mice. Although several fusion proteins induced immune responses to all the components of a polyprotein, we noted fusion proteins that abrogated immune response to some of the components. Since the expression levels of such fusion proteins were not affected, these data suggest that the immune recognition of certain components was altered by the fusion. Testing different DNA vectors in mice and macaques revealed that a combination of DNAs producing different forms of the same antigen generated more balanced immune responses, a desirable feature for an optimal AIDS vaccine. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195080      PMCID: PMC3115438          DOI: 10.1016/j.vaccine.2010.12.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  60 in total

Review 1.  Herpes simplex virus.

Authors:  Travis J Taylor; Mark A Brockman; Elizabeth E McNamee; David M Knipe
Journal:  Front Biosci       Date:  2002-03-01

2.  Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.

Authors:  R Wagner; M Graf; K Bieler; H Wolf; T Grunwald; P Foley; K Uberla
Journal:  Hum Gene Ther       Date:  2000-11-20       Impact factor: 5.695

3.  Enhancement of DNA vaccine potency in rhesus macaques by electroporation.

Authors:  Gillis Otten; Mary Schaefer; Barbara Doe; Hong Liu; Indresh Srivastava; Jan zur Megede; Derek O'Hagan; John Donnelly; Georg Widera; Dietmar Rabussay; Mark G Lewis; Susan Barnett; Jeffrey B Ulmer
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

4.  Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA.

Authors:  Marcus Graf; Ludwig Deml; Ralf Wagner
Journal:  Methods Mol Med       Date:  2004

5.  Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Authors:  G Widera; M Austin; D Rabussay; C Goldbeck; S W Barnett; M Chen; L Leung; G R Otten; K Thudium; M J Selby; J B Ulmer
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

Review 6.  Design and tests of an HIV vaccine.

Authors:  Andrew McMichael; Matilu Mwau; Tomas Hanke
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

7.  Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation.

Authors:  Z Wang; P J Troilo; X Wang; T G Griffiths; S J Pacchione; A B Barnum; L B Harper; C J Pauley; Z Niu; L Denisova; T T Follmer; G Rizzuto; G Ciliberto; E Fattori; N L Monica; S Manam; B J Ledwith
Journal:  Gene Ther       Date:  2004-04       Impact factor: 5.250

8.  Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation.

Authors:  Mikako Fujita; Hirofumi Akari; Akiko Sakurai; Akiko Yoshida; Tomoki Chiba; Keiji Tanaka; Klaus Strebel; Akio Adachi
Journal:  Microbes Infect       Date:  2004-07       Impact factor: 2.700

Review 9.  Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.

Authors:  Genoveffa Franchini; Sanjay Gurunathan; Lynn Baglyos; Stanley Plotkin; Jim Tartaglia
Journal:  Expert Rev Vaccines       Date:  2004-08       Impact factor: 5.217

10.  First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

Authors:  R R MacGregor; J D Boyer; K E Ugen; K E Lacy; S J Gluckman; M L Bagarazzi; M A Chattergoon; Y Baine; T J Higgins; R B Ciccarelli; L R Coney; R S Ginsberg; D B Weiner
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

View more
  20 in total

1.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.

Authors:  Viraj Kulkarni; Margherita Rosati; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Cristina Bergamaschi; Ashish K Singh; Candido Alicea; Bhabadeb Chowdhury; Gen-Mu Zhang; Eun-Young Kim; Steven M Wolinsky; Wensheng Huang; Yongjun Guan; Celia LaBranche; David C Montefiori; Kate E Broderick; Niranjan Y Sardesai; Antonio Valentin; Barbara K Felber; George N Pavlakis
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

3.  IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.

Authors:  Rashmi Jalah; Vainav Patel; Viraj Kulkarni; Margherita Rosati; Candido Alicea; Brunda Ganneru; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Kate E Broderick; Niranjan Y Sardesai; Celia LaBranche; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

4.  Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.

Authors:  Nicola Winstone; Aaron J Wilson; Gavin Morrow; Cesar Boggiano; Maria J Chiuchiolo; Mary Lopez; Marina Kemelman; Arielle A Ginsberg; Karl Mullen; John W Coleman; Chih-Da Wu; Sandeep Narpala; Ian Ouellette; Hansi J Dean; Feng Lin; Niranjan Y Sardesai; Holly Cassamasa; Dawn McBride; Barbara K Felber; George N Pavlakis; Alan Schultz; Michael G Hudgens; C Richter King; Timothy J Zamb; Christopher L Parks; Adrian B McDermott
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

5.  Enhanced immunostimulatory effects of DNA-encapsulated peptide hydrogels.

Authors:  Scott H Medina; Sandra Li; O M Zack Howard; Micah Dunlap; Anna Trivett; Joel P Schneider; Joost J Oppenheim
Journal:  Biomaterials       Date:  2015-03-23       Impact factor: 12.479

6.  HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques.

Authors:  Jinyao Li; Antonio Valentin; Viraj Kulkarni; Margherita Rosati; Rachel Kelly Beach; Candido Alicea; Drew Hannaman; Steven G Reed; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2013-04-26       Impact factor: 3.641

7.  Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.

Authors:  Viraj Kulkarni; Margherita Rosati; Antonio Valentin; Rashmi Jalah; Candido Alicea; Lei Yu; Yongjun Guan; Xiaoying Shen; Georgia D Tomaras; Celia LaBranche; David C Montefiori; Carmela Irene; Rajasekhar Prattipati; Abraham Pinter; Sean M Sullivan; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2013-07-02       Impact factor: 3.452

8.  Differential effects of IL-15 on the generation, maintenance and cytotoxic potential of adaptive cellular responses induced by DNA vaccination.

Authors:  Jinyao Li; Antonio Valentin; Sinnie Ng; Rachel Kelly Beach; Candido Alicea; Cristina Bergamaschi; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2015-01-02       Impact factor: 3.641

9.  Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.

Authors:  Monica Vaccari; Brandon F Keele; Steven E Bosinger; Melvin N Doster; Zhong-Min Ma; Justin Pollara; Anna Hryniewicz; Guido Ferrari; Yongjun Guan; Donald N Forthal; David Venzon; Claudio Fenizia; Tia Morgan; David Montefiori; Jeffrey D Lifson; Chris J Miller; Guido Silvestri; Margherita Rosati; Barbara K Felber; George N Pavlakis; James Tartaglia; Genoveffa Franchini
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.

Authors:  Antonio Valentin; Katherine McKinnon; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Guy R Pilkington; Jenifer Bear; Candido Alicea; Diego A Vargas-Inchaustegui; L Jean Patterson; Poonam Pegu; Namal P M Liyanage; Shari N Gordon; Monica Vaccari; Yichuan Wang; Alison E Hogg; Blake Frey; Yongjun Sui; Steven G Reed; Niranjan Y Sardesai; Jay A Berzofsky; Genoveffa Franchini; Marjorie Robert-Guroff; Barbara K Felber; George N Pavlakis
Journal:  Clin Immunol       Date:  2014-09-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.